InvestorsHub Logo

gew59

04/06/20 9:01 AM

#8850 RE: floydborga #8848

I believe the reason pktx can take Dry Eye drops all the way to market is because the medium to deliver aagp is probably saline or some other readily available solution. For AMD or Diabetes or..., aagp is applied to a cell (stem, islet...) and pktx does not have these - therefore, licensing is appropriate in other applications.

This is a great opportunity for pktx to be incharge of their own destiny and really add value to the stock.

SPORT19

05/14/20 2:08 PM

#9028 RE: floydborga #8848

So Floyd what do you think about the silence from the company and long shareholders?

TIA

SPORT19

05/16/20 2:37 PM

#9041 RE: floydborga #8848

Hey Floyd when do you think Smith gives shareholders an update on MacD progress?

TIA